We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.



Vaccine vials.

Vaccine Candidate Shows Promise Against Birth Defect-Causing Virus

An experimental mRNA vaccine against human cytomegalovirus (CMV), a common virus that can infect babies during pregnancy, elicited some of the most promising immune responses to date of any CMV vaccine candidate.
Someone holding their hands.

Drug Treatment for Rheumatoid Arthritis May Also Prevent It

Results from a Phase 2b clinical trial provides hope for arthritis sufferers after it was shown that the biologic drug abatacept reduces progression to this agonising chronic inflammatory disease.
Cell therapy.

Novel Design Improves CAR T-Cell Therapy for Childhood Leukemia

Scientists at St. Jude Children’s Research Hospital improved bispecific chimeric antigen receptor (CAR) T–cell immunotherapies for acute myeloid leukemia (AML), corroborated by computational analysis.
Computer-generated image of cells.

Risk of Secondary Cancer Investigated After CAR T-Cell Therapy

A study by University of Pennsylvania researchers shows that secondary cancer development is rare after CAR T-cell therapy and that many patients have achieved long-lasting remission.
A plastic model of a pair of lungs.

Cell Therapy Shows Promise for Severe Lung Condition in Small Trial

An initial trial suggests a new type of cell therapy could improve the prognosis of those who are critically ill with acute respiratory distress syndrome resulting from Covid-19.
T cells.

Technique Makes T Cells 100 Times More Potent at Killing Cancer Cells

Current immunotherapies work only against cancers of the blood and bone marrow. T cells engineered by Northwestern and UCSF were able to kill tumors derived from skin, lung and stomach in mice.
A capsule halved with drug molecules inside.

Breast Cancer Drug's Efficacy Can Be Restored After Resistance

Researchers have shown that targeting a protein called TACC3 (transforming acidic coiled-coil containing protein 3) can restore the effectiveness of the breast cancer drug T-DM1 if the cancer cells have developed resistance.
Two blood test vials held in a gloved hand.

Blood Tests Could Predict Poor CAR T-Cell Therapy Outcomes

Blood tests could predict outcomes of CAR T-cell therapy, helping to optimize cancer treatments and improve their safety and efficacy.
A close up of a glass vial containing a DNA molecule.

Cell Therapy Targets Brain Inflammation After Stroke

A new therapeutic for stroke based on University of Georgia research will soon enter clinical trials. The U.S. Food and Drug Administration cleared the new drug to enter a Phase 1b/2a clinical trial.
A person wearing gloves drawing up a vaccine into a syringe.

Single-Dose Dengue Vaccine Provides Nearly 80% Protection

Results from a Phase 3 clinical trial show that the vaccine is safe and effective for those aged 2–59 regardless of whether they have previously been infected with dengue.